biguanides has been researched along with Anemia, Megaloblastic in 1 studies
Biguanides: Derivatives of biguanide (the structure formula HN(C(NH)NH2)2) that are primarily used as oral HYPOGLYCEMIC AGENTS for the treatment of DIABETES MELLITUS, TYPE 2 and PREDIABETES.
biguanides : A class of oral hypoglycemic drugs used for diabetes mellitus or prediabetes treatment. They have a structure based on the 2-carbamimidoylguanidine skeleton.
Anemia, Megaloblastic: A disorder characterized by the presence of ANEMIA, abnormally large red blood cells (megalocytes or macrocytes), and MEGALOBLASTS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We screened 600 patients with type 2 diabetes treated with biguanides (phenformin or metformin) for a mean of 11." | 1.32 | Should we screen diabetic patients using biguanides for megaloblastic anaemia? ( Bonovas, S; Filioussi, K; Katsaros, T, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Filioussi, K | 1 |
| Bonovas, S | 1 |
| Katsaros, T | 1 |
1 other study available for biguanides and Anemia, Megaloblastic
| Article | Year |
|---|---|
Should we screen diabetic patients using biguanides for megaloblastic anaemia?
Topics: Adult; Aged; Aged, 80 and over; Anemia, Megaloblastic; Biguanides; Diabetes Mellitus, Type 2; Female | 2003 |